Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses ITGR in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ITGR in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Joseph Dziedzic | $1,235,000 | $0 | $5,999,951 | $0 | $1,323,766 | $0 | $112,615 | $8,671,332 |
| Former President and Chief Executive Officer | ||||||||
| Payman Khales | 637,019 | 0 | 2,149,878 | 0 | 363,631 | 0 | 61,332 | 3,211,860 |
| President and Chief Executive Officer | ||||||||
| Diron Smith | 499,135 | 0 | 1,724,858 | 0 | 321,007 | 0 | 23,964 | 2,568,964 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Andrew Senn | 434,135 | 250,000 | 799,959 | 0 | 195,190 | 0 | 28,640 | 1,707,924 |
| President, Cardio & Vascular | ||||||||
| Jim Stephens | 504,423 | 0 | 949,874 | 0 | 227,853 | 0 | 10,500 | 1,692,650 |
| President, Cardiac Rhythm Management & Neuromodulation | ||||||||
| Lindsay Blackwood | 365,385 | 50,000 | 1,024,856 | 0 | 203,656 | 0 | 0 | 1,643,897 |
| Senior Vice President, General Counsel and Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Joseph Dziedzic | $8,671,332 | $8,675,379 | $8,738,497 | −4,047 |
| Payman Khales | 3,211,860 | 1,976,810 | 4,036,646 | +1,235,050 |
| Diron Smith | 2,568,964 | 2,472,797 | 1,281,207 | +96,167 |
| Andrew Senn | 1,707,924 | — | — | — |
| Jim Stephens | 1,692,650 | 1,600,604 | — | +92,046 |
| Lindsay Blackwood | 1,643,897 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Diron Smith | EVP, Chief Financial Officer | 2026-05-08 | D | 2,063 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Diron Smith | EVP, Chief Financial Officer | 2026-05-08 | A | 2,063 | 0 | 0 | Common | Form 4 ↗ |
| Diron Smith | EVP, Chief Financial Officer | 2026-05-08 | D | 503 | 88 | 44,324 | Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | D | 479 | 88 | 42,229 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-15 | — | 1,963 | — | — | 1 insider, 2 accrual rows | ||
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | A | 491 | 0 | 0 | Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | A | 1,472 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-18 | — | 666 | — | — | 1 insider, 1 accrual row | ||
| Michael J. Coyle | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Aaron Kapito | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Sheila Antrum | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| James F. Flanagan | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Cheryl C. Capps | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Alvin (Tyrone) Jeffers | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Filippo Passerini | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Donald J. Spence | Director | 2026-05-20 | A | 2,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| M. Craig Maxwell | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-20 | — | 1,967 | — | — | 1 insider, 1 accrual row | ||
| Dividend-equivalent accruals | 2026-06-29 | — | 1,096 | — | — | 1 insider, 1 accrual row | ||
| Kirk K. Thor | Chief Human Resources Officer | 2026-06-30 | A | 6,120 | — | — | Common | Form 4 ↗ |
| Kirk K. Thor | Chief Human Resources Officer | 2026-06-30 | D | 6,120 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kirk K. Thor | Chief Human Resources Officer | 2026-06-30 | D | 2,409 | 93 | 225,121 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-06 | — | 892 | — | — | 1 insider, 1 accrual row | ||
| Milo Stephen Metcalf II | US - EVP, Operations | 2026-07-06 | A | 4,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Diron Smith | EVP, Chief Financial Officer | 2026-05-08 | D | 2,063 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Diron Smith | EVP, Chief Financial Officer | 2026-05-08 | A | 2,063 | 0 | 0 | Common | Form 4 ↗ |
| Diron Smith | EVP, Chief Financial Officer | 2026-05-08 | D | 503 | 88 | 44,324 | Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | D | 479 | 88 | 42,229 | Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | D | 1,472 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | A | 491 | 0 | 0 | Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | D | 491 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jim Stephens | President, CRM & Neuro | 2026-05-15 | A | 1,472 | 0 | 0 | Common | Form 4 ↗ |
| Tommy P. Thomas | VP, Corporate Controller | 2026-05-18 | A | 666 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael J. Coyle | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Aaron Kapito | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Sheila Antrum | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| James F. Flanagan | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Cheryl C. Capps | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Alvin (Tyrone) Jeffers | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Filippo Passerini | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| Donald J. Spence | Director | 2026-05-20 | A | 2,623 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| M. Craig Maxwell | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Common | Form 4 ↗ |
| James F. Hinrichs | Director | 2026-05-20 | A | 1,967 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John A. Harris | President, Glob Ops & Manu Tec | 2026-06-29 | A | 1,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kirk K. Thor | Chief Human Resources Officer | 2026-06-30 | A | 6,120 | — | — | Common | Form 4 ↗ |
| Kirk K. Thor | Chief Human Resources Officer | 2026-06-30 | D | 6,120 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kirk K. Thor | Chief Human Resources Officer | 2026-06-30 | D | 2,409 | 93 | 225,121 | Common | Form 4 ↗ |
| Milo Stephen Metcalf II | US - EVP, Operations | 2026-07-06 | A | 892 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Milo Stephen Metcalf II | US - EVP, Operations | 2026-07-06 | A | 4,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Payman Khales | RSU | 2025-10-24 | — | — | 7,543 | — | $549,960 |
| Payman Khales | RSU | 2025-01-17 | — | — | 3,782 | — | 533,262 |
| Payman Khales | PSU | 2025-01-17 | 1,640 | 3,280 | — | 6,560 | 533,394 |
| Payman Khales | PSU | 2025-01-17 | 1,891 | 3,782 | — | 7,564 | 533,262 |
| Diron Smith | RSU | 2025-01-17 | — | — | 4,078 | — | 574,998 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Payman Khales | $1,083,222 | $1,066,656 | $0 | 49.6% |
| Diron Smith | 574,998 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Lindsay Blackwood | RSU | 8,746 | — | $685,949 |
| Andrew Senn | RSU | 2,224 | — | 174,428 |
| Payman Khales | PSU | 8,084 | — | 634,028 |
| Andrew Senn | RSU | 3,846 | — | 301,642 |
| Joseph Dziedzic | RSU | 8,235 | — | 645,871 |
| Andrew Senn | PSU | 2,558 | — | 200,624 |
| Diron Smith | PSU | 874 | — | 68,548 |
| Diron Smith | RSU | 4,078 | — | 319,838 |
| Joseph Dziedzic | PSU | 49,408 | — | 3,875,069 |
| Diron Smith | RSU | 292 | — | 22,902 |
| Jim Stephens | PSU | 2,944 | — | 230,898 |
| Andrew Senn | PSU | 2,585 | — | 202,742 |
| Jim Stephens | RSU | 2,245 | — | 176,075 |
| Jim Stephens | RSU | 1,963 | — | 153,958 |
| Andrew Senn | RSU | 1,891 | — | 148,311 |
| Payman Khales | RSU | 7,543 | — | 591,597 |
| Joseph Dziedzic | PSU | 49,358 | — | 3,871,148 |
| Payman Khales | RSU | 43,060 | — | 3,377,196 |
| Diron Smith | PSU | 5,574 | — | 437,169 |
| Joseph Dziedzic | RSU | 19,391 | — | 1,520,836 |
| Joseph Dziedzic | PSU | 33,172 | — | 2,601,680 |
| Joseph Dziedzic | RSU | 14,184 | — | 1,112,451 |
| Payman Khales | RSU | 3,782 | — | 296,622 |
| Jim Stephens | PSU | 3,070 | — | 240,780 |
| Andrew Senn | PSU | 2,560 | — | 200,781 |
| Payman Khales | RSU | 1,348 | — | 105,724 |
| Diron Smith | RSU | 2,063 | — | 161,801 |
| Andrew Senn | RSU | 726 | — | 56,940 |
| Payman Khales | PSU | 5,428 | — | 425,718 |
| Diron Smith | PSU | 9,650 | — | 756,850 |
| Joseph Dziedzic | RSU | 11,753 | — | 921,788 |
| Payman Khales | PSU | 8,078 | — | 633,558 |
| Payman Khales | PSU | 5,171 | — | 405,562 |
| Jim Stephens | PSU | 4,282 | — | 335,837 |
| Diron Smith | RSU | 3,419 | — | 268,152 |
| Andrew Senn | PSU | 2,051 | — | 160,860 |
| Payman Khales | RSU | 1,923 | — | 150,821 |
| Jim Stephens | RSU | 1,517 | — | 118,978 |
| Diron Smith | PSU | 878 | — | 68,862 |
Our compensation philosophy is to provide a competitive compensation package that will attract, retain and motivate our executives to drive the Company's success through high performance and innovation, to link our executives' compensation to short- and long-term performance of the Company and to align our executives' compensation with the interests of our stockholders.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-22 | 28,727,674 | 393,504 | 10,160 | 98.65% | Passed |
| 2025 | 2025-05-21 | 31,879,361 | 716,649 | 5,029 | 97.8% | Passed |
| 2024 | 2024-05-22 | 31,020,611 | 628,696 | 6,648 | 98.01% | Passed |
| 2023 | 2023-05-24 | 29,514,394 | 1,397,401 | 9,336 | 95.48% | Passed |
| 2022 | 2022-05-18 | 29,935,440 | 1,054,541 | 14,142 | 96.6% | Passed |
| 2021 | 2021-05-19 | 30,081,333 | 976,609 | 19,671 | 96.86% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-22 | 98.65%a |
| 2025 | 2025-05-21 | 97.8%b |
| 2024 | 2024-05-22 | 98.01%c |
a. Approved under the standard stated in the filing — “Abstentions will not constitute votes cast on any of these proposals and therefore will not affect the outcome of these proposals.”.
b. Approved under the standard stated in the filing — “Abstentions will not constitute votes cast on either of these proposals and therefore will not affect the outcome of these proposals.”.
c. Approved under the standard stated in the filing — “Abstentions will not constitute votes cast on either of these proposals and therefore will not affect the outcome of these proposals.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 86 : 1 |
|---|---|
| CEO total compensation | $3,836,523 |
| Median employee compensation | $44,550 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Pamela G. BaileyIndependent · Board Chair · Corporate Governance and Nominating · Technology Strategy · Not standing for re-election | $140,000 | $239,900 | $0 | $0 | — | $379,900 |
| James F. HinrichsIndependent · Audit (Chair) · Compensation and Organization · Technology Strategy | 110,000 | 179,984 | 0 | 0 | — | 289,984 |
| Donald J. SpenceIndependent · Audit · Compensation and Organization (Chair) · Corporate Governance and Nominating · Technology Strategy | 98,901 | 179,984 | 0 | 0 | — | 278,885 |
| M. Craig MaxwellIndependent · Corporate Governance and Nominating · Technology Strategy (Chair) | 96,099 | 179,984 | 0 | 0 | — | 276,083 |
| Jean HobbyIndependent · Corporate Governance and Nominating (Chair) · Technology Strategy · Not standing for re-election | 90,000 | 179,984 | 0 | 0 | — | 269,984 |
| Sheila AntrumIndependent · Audit · Compensation and Organization · Technology Strategy | 90,000 | 179,984 | 0 | 0 | — | 269,984 |
| Filippo PasseriniIndependent · Audit · Compensation and Organization · Technology Strategy | 90,000 | 179,984 | 0 | 0 | — | 269,984 |
| Alvin (Tyrone) JeffersIndependent · Audit · Corporate Governance and Nominating · Technology Strategy | 90,000 | 179,984 | 0 | 0 | — | 269,984 |
| Cheryl C. CappsIndependent · Compensation and Organization · Corporate Governance and Nominating · Technology Strategy | 80,000 | 179,984 | 0 | 0 | — | 259,984 |
| Michael J. CoyleIndependent · Audit · Compensation and Organization · Technology Strategy · Newly elected | 42,766 | 164,998 | 0 | 0 | — | 207,764 |
| William B. Summers, JrIndependent · Not standing for re-election · Departed during FY | 35,110 | — | 0 | 0 | — | 35,110 |
| Aaron KapitoIndependent · Compensation and Organization · Technology Strategy · Newly elected | 0 | 0 | 0 | 0 | — | 0 |
| Payman KhalesEmployee director · Technology Strategy · Newly elected | 0 | 0 | 0 | — | — | 0 |
| James F. FlanaganIndependent · Audit · Technology Strategy · Newly elected | 0 | 0 | 0 | 0 | — | 0 |
| Joseph W. DziedzicEmployee director · Not standing for re-election · Departed during FY | 0 | 0 | 0 | — | — | 0 |
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 15,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $962,876 |
| Equity awards (grant-date value) | $1,844,770 |
| All other compensation | $0 |
| Total cost of the board | $2,807,646 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Integer Holdings Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Integer Holdings Corp.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Masimo Corporation | 2024 | Joe Kiani | $1,209,181 | $10,259,983 | $3,420,105 | $0 | $15,932,345 |
| 2 | Merit Medical Systems, Inc. | 2025 | Fred Lampropoulos | 1,890,000 | 9,313,606 | 0 | 1,882,894 | 13,755,143 |
| 3 | Haemonetics Corporation | 2026 | Christopher Simon | 1,100,008 | 7,561,987 | 1,504,968 | 1,834,250 | 12,044,701 |
| 4 | Plexus Corp. | 2025 | Todd Kelsey | 1,100,000 | 7,766,185 | 0 | 1,671,694 | 10,839,258 |
| 5 | Envista Holdings Corporation | 2025 | Paul Keel | 1,100,000 | 5,440,152 | 1,360,045 | 2,486,550 | 10,559,567 |
| 6 | Avanos Medical, Inc. | 2025 | David Pacitti | 751,705 | 7,000,000 | 0 | 1,148,667 | 9,469,803 |
| 7 | Integra LifeSciences Holdings Corporation | 2025 | Mojdeh Poul | 1,009,616 | 5,219,868 | 2,250,011 | 174,563 | 9,375,551 |
| 8 | Enovis Corporation | 2025 | Damien McDonald | 634,615 | 7,262,644 | 0 | 812,749 | 9,242,161 |
| 9 | Integer Holdings Corp | 2025 | Joseph Dziedzic | 1,235,000 | 5,999,951 | 0 | 1,323,766 | 8,671,332 |
| 10 | Nordson Corporation | 2025 | Sundaram Nagarajan | 1,049,385 | 3,514,413 | 1,519,547 | 1,327,472 | 8,153,900 |
| 11 | Methode Electronics, Inc. | 2026 | Jonathan DeGaynor | 1,018,269 | 4,456,045 | 0 | 2,562,500 | 8,090,755 |
| 12 | LivaNova PLC | 2025 | Vladimir Makatsaria | 956,115 | 4,303,092 | 1,374,999 | 1,287,656 | 8,047,217 |
| 13 | CONMED Corporation | 2025 | Patrick Beyer | 891,100 | 2,499,971 | 2,499,977 | 1,129,469 | 7,634,873 |
| 14 | OSI Systems, Inc. | 2025 | Ajay Mehra | 621,448 | 5,269,720 | 0 | 1,500,000 | 7,512,141 |
| 15 | Benchmark Electronics, Inc. | 2025 | Jeffrey Benck | 1,025,885 | 5,000,000 | 0 | 1,278,570 | 7,411,869 |
| 16 | Orthofix Medical Inc. | 2025 | Massimo Calafiore | 848,322 | 4,499,988 | 1,500,009 | 445,579 | 7,310,039 |
| 17 | Teleflex Incorporated | 2025 | Liam Kelly | 1,144,400 | 2,005,604 | 2,886,518 | 227,280 | 6,732,419 |
| 18 | ICU Medical, Inc. | 2025 | Vivek Jain | 775,000 | 4,500,023 | 0 | 1,162,500 | 6,452,042 |
| 19 | Bruker Corporation | 2025 | Frank Laukien | 976,554 | 1,623,407 | 1,488,109 | 587,270 | 4,706,388 |
| 20 | Varex Imaging Corporation | 2025 | Sunny Sanyal | 815,816 | 2,662,978 | 0 | 1,131,894 | 4,634,688 |
| 21 | Globus Medical, Inc. | 2025 | Keith Pfeil | 479,467 | 0 | 2,982,347 | 783,000 | 4,400,159 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Integer Holdings Corp | 85.75% | PSU 66 · RSU 33 | Yes — Relative TSR versus peer group | Frederic W. Cook & Co., Inc. |
| Avanos Medical, Inc. | 139% | PSU 50 · RSU 25 · Options 25 | No | Meridian Compensation Partners |
| Benchmark Electronics, Inc. | 95.87% | PSU 50 · RSU 50 | No | Pearl Meyer & Partners, LLC |
| Bruker Corporation | 43.0% | RSU 52 · Options 48 | not disclosed | Aon's Human Capital Solutions Practice |
| CONMED Corporation | 126.8% | Options 50 · PSU 50 | Yes — rTSR | Compensia, Inc. |
| Enovis Corporation | 92.2% | PSU 50 · RSU 50 | Yes — Relative TSR vs. S&P 500 Health Care Equipment Select Industry Index | FW Cook |
| Envista Holdings Corporation | 151% | PSU 60 · Options 20 · RSU 20 | No | Frederic W. Cook & Co, Inc. |
| Globus Medical, Inc. | 102% | Options 100 | not disclosed | FW Cook |
| Haemonetics Corporation | 133.4% | PSU 60 · RSU 20 · Options 20 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners, LLC |
| ICU Medical, Inc. | 150% | PSU 50 · RSU 50 | No | Compensia |
| Integra LifeSciences Holdings Corporation | 40% | PSU 50 · Options 25 · RSU 25 | No | WTW |
| LivaNova PLC | 122.4% | PSU 50 · RSU 25 · Options 25 | No | Pearl Meyer |
| Masimo Corporation | 134% | PSU 75 · Options 25 | Yes — Three-Year Cumulative Relative TSR | FW Cook |
| Merit Medical Systems, Inc. | 124.53% | PSU 60 · RSU 40 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners, LLC |
| Methode Electronics, Inc. | 200% | RSU 50 · PSU 50 | Yes — Total Shareholder Return (TSR) | Frederic W. Cook & Co., Inc. |
| Nordson Corporation | not disclosed | not disclosed | not disclosed | FW Cook |
| Orthofix Medical Inc. | 47.7% | PSU 50 · RSU 25 · Options 25 | No | Meridian Compensation Partners |
| OSI Systems, Inc. | not disclosed | PSU 100 | No | Pearl Meyer |
| Plexus Corp. | 112.6% | PSU 50 · RSU 50 | Yes — Relative Total Shareholder Return (TSR) | Exequity LLP |
| Teleflex Incorporated | 25.9% | Options 55 · RSU 25 · PSU 20 | Yes — Absolute TSR | FW Cook |
| Varex Imaging Corporation | 137.7% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Joseph Dziedzic | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Summary Compensation Table” · page 44. As printed: 8,671,332. Filing ↗machine: t48 · r17 · c21 · span 738226–738235 |
| 2 | Section 01, Payman Khales | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Summary Compensation Table” · page 44. As printed: 3,211,860. Filing ↗machine: t48 · r2 · c21 · span 701423–701432 |
| 3 | Section 01, Diron Smith | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Summary Compensation Table” · page 44. As printed: 2,568,964. Filing ↗machine: r5 · c48 · span 710633–710642 |
| 4 | Section 01, Andrew Senn | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Summary Compensation Table” · page 44. As printed: 1,707,924. Filing ↗machine: r11 · c48 · span 725405–725414 |
| 5 | Section 01, Jim Stephens | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Summary Compensation Table” · page 44. As printed: 1,692,650. Filing ↗machine: r14 · c48 · span 730764–730773 |
| 6 | Section 01, Lindsay Blackwood | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Summary Compensation Table” · page 44. As printed: 1,643,897. Filing ↗machine: r8 · c48 · span 719603–719612 |
| 7 | Section 03, Payman Khales RSU | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t50 · r8 · c16 · span 787481–787486 |
| 8 | Section 03, Payman Khales RSU | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t50 · r5 · c16 · span 779311–779316 |
| 9 | Section 03, Payman Khales PSU | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t50 · r6 · c13 · span 781500–781505 |
| 10 | Section 03, Payman Khales PSU | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t50 · r5 · c16 · span 779311–779316 |
| 11 | Section 03, Diron Smith RSU | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t50 · r10 · c16 · span 791414–791419 |
| 12 | Section 07, pay ratio | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “CEO Pay Ratio”. As printed: 86 : 1. Filing ↗machine: span 1046698–1046705 |
| 13 | Section 08, Pamela G. Bailey | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 379,900. Filing ↗machine: t67 · r3 · c9 · span 1191651–1191658 |
| 14 | Section 08, James F. Hinrichs | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 289,984. Filing ↗machine: t67 · r6 · c9 · span 1196146–1196153 |
| 15 | Section 08, Donald J. Spence | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 278,885. Filing ↗machine: t67 · r11 · c9 · span 1203640–1203647 |
| 16 | Section 08, M. Craig Maxwell | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 276,083. Filing ↗machine: t67 · r9 · c9 · span 1200643–1200650 |
| 17 | Section 08, Jean Hobby | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 269,984. Filing ↗machine: t67 · r7 · c9 · span 1197649–1197656 |
| 18 | Section 08, Sheila Antrum | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 269,984. Filing ↗machine: t67 · r2 · c9 · span 1190112–1190119 |
| 19 | Section 08, Filippo Passerini | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 269,984. Filing ↗machine: t67 · r10 · c9 · span 1202142–1202149 |
| 20 | Section 08, Alvin (Tyrone) Jeffers | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 269,984. Filing ↗machine: r8 · c9 · span 1199145–1199152 |
| 21 | Section 08, Cheryl C. Capps | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 259,984. Filing ↗machine: t67 · r4 · c9 · span 1193148–1193155 |
| 22 | Section 08, Michael J. Coyle | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 207,764. Filing ↗machine: t67 · r5 · c9 · span 1194646–1194653 |
| 23 | Section 08, William B. Summers, Jr | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 35,110. Filing ↗machine: t67 · r12 · c4 · span 1204618–1204624 |
| 24 | Section 08, Aaron Kapito | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 25 | Section 08, Payman Khales | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 26 | Section 08, James F. Flanagan | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 27 | Section 08, Joseph W. Dziedzic | DEF 14A | 2026-04-06 | 0001114483-26-000009 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 28 | Section 02, Diron Smith 2026-05-08 | Form 4 | 2026-05-12 | 0001977225-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Diron Smith 2026-05-08 | Form 4 | 2026-05-12 | 0001977225-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Diron Smith 2026-05-08 | Form 4 | 2026-05-12 | 0001977225-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Jim Stephens 2026-05-15 | Form 4 | 2026-05-19 | 0001978852-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Jim Stephens 2026-05-15 | Form 4 | 2026-05-19 | 0001978852-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Jim Stephens 2026-05-15 | Form 4 | 2026-05-19 | 0001978852-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Jim Stephens 2026-05-15 | Form 4 | 2026-05-19 | 0001978852-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Jim Stephens 2026-05-15 | Form 4 | 2026-05-19 | 0001978852-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Tommy P. Thomas 2026-05-18 | Form 4 | 2026-05-22 | 0001730071-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Michael J. Coyle 2026-05-20 | Form 4 | 2026-05-22 | 0001233311-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Aaron Kapito 2026-05-20 | Form 4 | 2026-05-22 | 0002122528-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Sheila Antrum 2026-05-20 | Form 4 | 2026-05-22 | 0001843602-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, James F. Flanagan 2026-05-20 | Form 4 | 2026-05-22 | 0002055648-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Cheryl C. Capps 2026-05-20 | Form 4 | 2026-05-22 | 0001843623-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Alvin (Tyrone) Jeffers 2026-05-20 | Form 4 | 2026-05-22 | 0001738895-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Filippo Passerini 2026-05-20 | Form 4 | 2026-05-22 | 0001263346-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Donald J. Spence 2026-05-20 | Form 4 | 2026-05-22 | 0001333002-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, M. Craig Maxwell 2026-05-20 | Form 4 | 2026-05-22 | 0001254378-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, James F. Hinrichs 2026-05-20 | Form 4 | 2026-05-22 | 0001506974-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, John A. Harris 2026-06-29 | Form 4 | 2026-07-01 | 0001689261-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Kirk K. Thor 2026-06-30 | Form 4 | 2026-07-01 | 0001726955-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Kirk K. Thor 2026-06-30 | Form 4 | 2026-07-01 | 0001726955-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Kirk K. Thor 2026-06-30 | Form 4 | 2026-07-01 | 0001726955-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Milo Stephen Metcalf II 2026-07-06 | Form 4 | 2026-07-10 | 0002144805-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Milo Stephen Metcalf II 2026-07-06 | Form 4 | 2026-07-10 | 0002144805-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 06, 2026 vote | Form 8-K | 2026-05-22 | 0001114483-26-000021 | Item 5.07 · say-on-pay result. As reported: 98.65% (votes for as printed: 28,727,674). Filing ↗ |
| 54 | Section 06, 2025 vote | Form 8-K | 2025-05-28 | 0001114483-25-000116 | Item 5.07 · say-on-pay result. As reported: 97.8% (votes for as printed: 31,879,361). Filing ↗ |
| 55 | Section 06, 2024 vote | Form 8-K | 2024-05-23 | 0001114483-24-000086 | Item 5.07 · say-on-pay result. As reported: 98.01% (votes for as printed: 31,020,611). Filing ↗ |
| 56 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 57 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 58 | Section 09b board cost (computed) | Computed | — | computed | Cash 962,876 + equity 1,844,770 + all other 0 = 2,807,646, summed across the director compensation table rows.machine: formula: Σ = 2,807,646 |
| 59 | Masimo Corporation, Section 10b CEO total | DEF 14A | 2025-03-26 | 0001104659-25-027887 | CEO total compensation as printed in Masimo Corporation's own proxy. As printed: 15,932,345. Filing ↗machine: span 1265493–1265503 |
| 60 | Merit Medical Systems, Inc., Section 10b CEO total | DEF 14A | 2026-03-31 | 0000856982-26-000013 | CEO total compensation as printed in Merit Medical Systems, Inc.'s own proxy. As printed: 13,755,143. Filing ↗machine: r21 · c8 · span 1277869–1277879 |
| 61 | Haemonetics Corporation, Section 10b CEO total | DEF 14A | 2026-06-09 | 0000313143-26-000074 | CEO total compensation as printed in Haemonetics Corporation's own proxy. As printed: 12,044,701. Filing ↗machine: span 718173–718183 |
| 62 | Plexus Corp., Section 10b CEO total | DEF 14A | 2025-12-22 | 0001140361-25-046290 | CEO total compensation as printed in Plexus Corp.'s own proxy. As printed: 10,839,258. Filing ↗machine: r2 · c22 · span 872884–872895 |
| 63 | Envista Holdings Corporation, Section 10b CEO total | DEF 14A | 2026-04-07 | 0001757073-26-000031 | CEO total compensation as printed in Envista Holdings Corporation's own proxy. As printed: 10,559,567. Filing ↗machine: span 692624–692634 |
| 64 | Avanos Medical, Inc., Section 10b CEO total | DEF 14A | 2026-03-12 | 0001104659-26-027106 | CEO total compensation as printed in Avanos Medical, Inc.'s own proxy. As printed: 9,469,803. Filing ↗machine: r1 · c53 · span 1674377–1674386 |
| 65 | Integra LifeSciences Holdings Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0000917520-26-000015 | CEO total compensation as printed in Integra LifeSciences Holdings Corporation's own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213 |
| 66 | Enovis Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001493152-26-015302 | CEO total compensation as printed in Enovis Corporation's own proxy. As printed: 9,242,161. Filing ↗machine: r1 · c37 · span 876874–876883 |
| 67 | Integer Holdings Corp (subject), Section 10b CEO total | DEF 14A | 2026-04-06 | 0001114483-26-000009 | CEO total compensation as printed in Integer Holdings Corp's own proxy. As printed: 8,671,332. Filing ↗machine: t48 · r17 · c21 · span 738226–738235 |
| 68 | Nordson Corporation, Section 10b CEO total | DEF 14A | 2026-01-16 | 0001193125-26-014662 | CEO total compensation as printed in Nordson Corporation's own proxy. As printed: 8,153,900. Filing ↗machine: r4 · c29 · span 1301788–1301797 |
| 69 | Methode Electronics, Inc., Section 10b CEO total | DEF 14A | 2026-07-31 | 0001140361-26-030317 | CEO total compensation as printed in Methode Electronics, Inc.'s own proxy. As printed: 8,090,755. Filing ↗machine: r2 · c22 · span 718592–718601 |
| 70 | LivaNova PLC, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001104659-26-050937 | CEO total compensation as printed in LivaNova PLC's own proxy. As printed: 8,047,217. Filing ↗machine: t117 · r3 · c50 · span 1095329–1095338 |
| 71 | CONMED Corporation, Section 10b CEO total | DEF 14A | 2026-04-07 | 0000816956-26-000047 | CEO total compensation as printed in CONMED Corporation's own proxy. As printed: 7,634,873. Filing ↗machine: r3 · c27 · span 1186564–1186573 |
| 72 | OSI Systems, Inc., Section 10b CEO total | DEF 14A | 2025-10-22 | 0001104659-25-101517 | CEO total compensation as printed in OSI Systems, Inc.'s own proxy. As printed: 7,512,141. Filing ↗machine: r1 · c54 · span 1051906–1051915 |
| 73 | Benchmark Electronics, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001193125-26-161703 | CEO total compensation as printed in Benchmark Electronics, Inc.'s own proxy. As printed: 7,411,869. Filing ↗machine: r4 · c25 · span 1354584–1354593 |
| 74 | Orthofix Medical Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-191716 | CEO total compensation as printed in Orthofix Medical Inc.'s own proxy. As printed: 7,310,039. Filing ↗machine: t96 · r4 · c16 · span 1472329–1472338 |
| 75 | Teleflex Incorporated, Section 10b CEO total | DEF 14A | 2026-04-13 | 0000096943-26-000039 | CEO total compensation as printed in Teleflex Incorporated's own proxy. As printed: 6,732,419. Filing ↗machine: span 558736–558745 |
| 76 | ICU Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0000883984-26-000019 | CEO total compensation as printed in ICU Medical, Inc.'s own proxy. As printed: 6,452,042. Filing ↗machine: r2 · c24 · span 432290–432299 |
| 77 | Bruker Corporation, Section 10b CEO total | DEF 14A | 2026-04-10 | 0001193125-26-151305 | CEO total compensation as printed in Bruker Corporation's own proxy. As printed: 4,706,388. Filing ↗machine: t77 · r2 · c18 · span 987303–987312 |
| 78 | Varex Imaging Corporation, Section 10b CEO total | DEF 14A | 2025-12-29 | 0001104659-25-124842 | CEO total compensation as printed in Varex Imaging Corporation's own proxy. As printed: 4,634,688. Filing ↗machine: r1 · c53 · span 911140–911149 |
| 79 | Globus Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027196 | CEO total compensation as printed in Globus Medical, Inc.'s own proxy. As printed: 4,400,159. Filing ↗machine: r5 · c21 · span 344690–344699 |
| 80 | Section 10a, Masimo Corporation reciprocity | DEF 14A | — | 0001104659-25-027887 | Masimo Corporation's most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 81 | Section 10a, Plexus Corp. reciprocity | DEF 14A | — | 0001140361-25-046290 | Plexus Corp.'s most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 82 | Section 10a, Methode Electronics, Inc. reciprocity | DEF 14A | — | 0001140361-26-030317 | Methode Electronics, Inc.'s most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 83 | Section 10a, OSI Systems, Inc. reciprocity | DEF 14A | — | 0001104659-25-101517 | OSI Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 84 | Section 10a, Avanos Medical, Inc. reciprocity | DEF 14A | — | 0001104659-26-027106 | Avanos Medical, Inc. names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 85 | Section 10a, Bruker Corporation reciprocity | DEF 14A | — | 0001193125-26-151305 | Bruker Corporation's most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 86 | Section 10a, CONMED Corporation reciprocity | DEF 14A | — | 0000816956-26-000047 | CONMED Corporation's most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 87 | Section 10a, Envista Holdings Corporation reciprocity | DEF 14A | — | 0001757073-26-000031 | Envista Holdings Corporation names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 88 | Section 10a, ICU Medical, Inc. reciprocity | DEF 14A | — | 0000883984-26-000019 | ICU Medical, Inc. names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 89 | Section 10a, Integra LifeSciences Holdings Corporation reciprocity | DEF 14A | — | 0000917520-26-000015 | Integra LifeSciences Holdings Corporation names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 90 | Section 10a, Nordson Corporation reciprocity | DEF 14A | — | 0001193125-26-014662 | Nordson Corporation names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 91 | Section 10a, Orthofix Medical Inc. reciprocity | DEF 14A | — | 0001193125-26-191716 | Orthofix Medical Inc. names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 92 | Section 10a, Varex Imaging Corporation reciprocity | DEF 14A | — | 0001104659-25-124842 | Varex Imaging Corporation's most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 93 | Section 10a, Merit Medical Systems, Inc. reciprocity | DEF 14A | — | 0000856982-26-000013 | Merit Medical Systems, Inc. names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 94 | Section 10a, LivaNova PLC reciprocity | DEF 14A | — | 0001104659-26-050937 | LivaNova PLC names Integer Holdings Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 95 | Section 10a, Teleflex Incorporated reciprocity | DEF 14A | — | 0000096943-26-000039 | Teleflex Incorporated's most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 96 | Section 10a, Haemonetics Corporation reciprocity | DEF 14A | — | 0000313143-26-000074 | Haemonetics Corporation's most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |
| 97 | Section 10a, Benchmark Electronics, Inc. reciprocity | DEF 14A | — | 0001193125-26-161703 | Benchmark Electronics, Inc.'s most recent proxy was read; its disclosed peer group does not include Integer Holdings Corp. Filing ↗ |